Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Sun Pharma says USFDA issues at Halol over, two specialty drugs may get nod - The Pharma Times | Pharma & Health Care News Portal

Sun Pharma says USFDA issues at Halol over, two specialty drugs may get nod

New Delhi, June 13, 2018: Sun Pharmaceutical Industries today announced the resolution of regulatory compliance issues at Halol plant.

Halol plant was served a warning letter by US Food and Drug Administration in
December 2015. No new products manufactured at the facility have been approved since September 2014 when it received adverse observations from the US regulator.
In a stock exchange notification on Tuesday, the company said it has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its Halol plant during February 12-23.
“The agency concluded that the inspection is now closed and the issues contained in the warning letter issued in December 2015 have been addressed,” the company said.
In a statement Dilip Shanghvi, managing director, Sun Pharma said, “This is an important development for Sun Pharma. We remain committed to following the highest levels of quality and 24×7 good manufacturing practices compliance at all our manufacturing facilities globally.”
The resolution of Halol plant is important for revival of Sun Pharma’s US business which contributed around 35 per cent of its consolidated sales in last fiscal. The company has guided for low double digit growth in FY 19 and is targeting growth from all markets.
The resolution of issues could lead to approvals for two specialty products – eye drug Xelpros and anti epileptic drug Elepsia. Both products have been filed from Halol plant and have been denied approval so far because of regulatory issues.
The Pharma Times News Bureau

Share
Published by
The Pharma Times News Bureau
6 years ago

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

5 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago